Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Udenyca® Onbody™ (pegfilgrastim-cbqv) – First-time biosimilar launch

February 21, 2024 - Coherus announced the launch of Udenyca Onbody (pegfilgrastim-cbqv), a biosimilar to Amgen’s Neulasta® OnPro® (pegfilgrastim).

Download PDF

Rx navigation